Milnacipran and Neurocognition, Pain and Fatigue in Fibromyalgia: A 13-week Randomized, Placebo Controlled Cross Over Trial
Phase of Trial: Phase III
Latest Information Update: 27 Oct 2014
Price : $35 *
At a glance
- Drugs Milnacipran (Primary)
- Indications Fibromyalgia; Musculoskeletal pain
- Focus Therapeutic Use
- 18 May 2013 Status changed from active, no longer recruiting to completed.
- 18 May 2013 Results presented at the 166th Annual Meeting of the American Psychiatric Association.
- 24 Apr 2013 New trial record